British drugs firm GSK has been accused of burying a report said to prove a link between its medication Zantac and cancer, a ...

The common claim in the lawsuits is that a contaminant in Zantac (ranitidine) called N-nitrosodimethylamine (NDMA) – as well as other ranitidine products – increased the risk of cancer.

There are no plans to ban the manufacture, distribution, or sale of Ranitidine, a common medication for reducing stomach acid, Minister of State for Health Anupriya Patel informed the Rajya Sabha ...

In September and October 2019, GSK suspended its distribution of Zantac (the brand name for the drug ranitidine) and issued a voluntary recall after studies demonstrated that, by interacting with ...